Award

Blood glucose consumables and EQA materials

  • NHS Wales Shared Services Partnership - Procurement Services

F15: Voluntary ex ante transparency notice

Notice identifier: 2021/S 000-026517

Procurement identifier (OCID): ocds-h6vhtk-02ef02

Published 22 October 2021, 12:45pm



Section one: Contracting authority/entity

one.1) Name and addresses

NHS Wales Shared Services Partnership - Procurement Services

4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw

Cardiff

CF47 9DT

Contact

Marc Withers

Email

marc.withers@wales.nhs.uk

Telephone

+44 1443848585

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

http://nwssp.nhs.wales/ourservices/procurement-services/

Buyer's address

https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Blood glucose consumables and EQA materials

two.1.2) Main CPV code

  • 33696200 - Blood-testing reagents

two.1.3) Type of contract

Supplies

two.1.4) Short description

Supply of blood glucose consumables (testing strips) and EQA materials.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £237,488.02

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKL15 - Central Valleys
Main site or place of performance

CTM UHB region

two.2.4) Description of the procurement

Blood glucose monitoring refers to testing the concentration of glucose in the blood to aid the management of Diabetes types 1 & 2.

Similarly, monitoring the presence of ketones in the blood is also important as high levels can result in complications such as Ketoacidosis.

This procurement will involve the supply of Blood glucose monitoring equipment(meters) and associated consumables (Test-strips for the

Point of Care Testing Service at Cwm Taf Morgannwg University Health Board. This will be to renew the

existing arrangement with Abbott Laboratories Ltd.

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

The current contract with Abbott Laboratories Ltd ended on the 30th of September 2021. The Health Board's intention was to enter into a new contract with Abbott Laboratories Ltd through a direct award under the terms of a Public Sector Framework.

This would enable sufficient time for NWSSP Shared Services Procurement to undertake a formal market-test exercise, to award a new All Wales Framework. Currently, the Health Board's POCT Service is not able to contemplate an alternative supplier for the reasons outlined

below:

The migration of operators to a completely new device would need to be completed on a rolling basis with full training for every member of staff. The POCT Team is not in a position to support this due to the extra training demands in relation to Covid-19 and the clinical areas are still finding it difficult to release staff to attend training, due to staffing pressures.

The current management of testing allows for staff to move flexibly from one area or site to another. During the process of migration, this flexibility will be lost to a degree with some areas using the new meter and other areas using the existing meter, this could expose the HB

to risk, given current staffing pressures.

The Health Board cannot find a Public Sector Framework with which to engage with Abbott Laboratories Ltd at this time and therefore, there is no opportunity to make a compliant direct award.

For the reasons outlined above and to ensure continuity of service for patient care, the Health Board has no option but to enter into a 12-month agreement without any formal underpinning Framework arrangement.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section five. Award of contract/concession

A contract/lot is awarded: Yes

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract

8 October 2021

five.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

Abbott Laboratories Ltd

Abbott House, Vanwall Business Park

Maidenhead

SL64XE

Country

United Kingdom

NUTS code
  • UK - United Kingdom
The contractor/concessionaire is an SME

No

five.2.4) Information on value of contract/lot/concession (excluding VAT)

Total value of the contract/lot/concession: £237,488.02


Section six. Complementary information

six.3) Additional information

NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=115133.

(WA Ref:115133)

six.4) Procedures for review

six.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

Telephone

+44 2079477501

Country

United Kingdom